Status:
COMPLETED
Evaluating UTI Outcomes in at Risk Populations
Lead Sponsor:
Pathnostics
Conditions:
Urinary Tract Infections
Complicated Urinary Tract Infection
Eligibility:
All Genders
65+ years
Brief Summary
This is a multicenter, observational comparative cohort, study to evaluate the UTI related adverse event rates between Guidance® UTI clinical pathway versus the current traditional clinical pathways f...
Detailed Description
Clinical sites will be identified by an internal database, prepared by the sponsor, based on previous experience with the sites. Study allocation will based on their current usage of Guidance® UTI and...
Eligibility Criteria
Inclusion
- Inclusion
- Male or female participants ≥ 65 years of age, no predetermined quotas or ratios for gender participation.
- High suspicion of active UTI
- Ability to provide/obtain a clean catch or sterile urine specimen
- Willing to adhere to follow-up schedule as stated in schedule of events
- Permanent residence in the same state in which they were consented for the study
- Able to provide informed consent
- Exclusion
- Participation in another UTI trial during the study period
- Patients in hospice-care or limited life expectancy of ≤1 month)
- Inability to provide informed consent and/or respond independently to follow up surveys
- If the provider deems that a urine culture or Guidance UTI is not necessary in clinical management
Exclusion
Key Trial Info
Start Date :
July 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 29 2024
Estimated Enrollment :
7921 Patients enrolled
Trial Details
Trial ID
NCT05385536
Start Date
July 18 2022
End Date
March 29 2024
Last Update
May 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dispatch Health
Denver, Colorado, United States, 80205